Mycophenolate mofetil and triptolide alleviating airway inflammation in asthmatic model mice partly by inhibiting bone marrow eosinophilopoiesis

International Immunopharmacology

Volumn 8, Issue 7, 2008, Pages 1039-1048

  Mao, Hui ^a   Chen, Xue rong ^a   Yi, Qun ^a   Li, Su yun ^b   Wang, Zeng Li ^a   Li, Fu yu ^a  

^a SICHUAN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Asthma; Bone marrow; Eosinophilopoiesis; Mycophenolate mofetil; Triptolide

Indexed keywords

BROXURIDINE; CD34 ANTIGEN; CHEMOKINE RECEPTOR CCR3; EOTAXIN; INTERLEUKIN 5; INTERLEUKIN 5 RECEPTOR ALPHA; MESSENGER RNA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OVALBUMIN; SODIUM CHLORIDE; TRIPTOLIDE;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; BONE MARROW; BONE MARROW CELL; CELL MIGRATION; CONTROLLED STUDY; DISEASE MODEL; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; EOSINOPHILIPOIESIS; HISTOPATHOLOGY; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATORY CELL; LUNG LAVAGE; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; RESPIRATORY TRACT INFLAMMATION; TREATMENT DURATION; WESTERN BLOTTING;

ANIMALS; ASTHMA; BONE MARROW; DITERPENES; EOSINOPHILS; EPOXY COMPOUNDS; HEMATOPOIESIS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-5; MALE; MICE; MICE, INBRED BALB C; MYCOPHENOLIC ACID; PHENANTHRENES; RECEPTORS, CCR3;

EID: 51749101292     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.03.009     Document Type: Article

References (37)

1. Dorman S.C., Efthimiadis A., Babirad I., Watson R.M., Denburg J.A., Hargreave F.E., et al. Sputum CD34+IL-5Ralpha+ cells increase after allergen: evidence for in situ eosinophilopoiesis. Am J Respir Crit Care Med 169 (2004) 573-577
2. Sitkauskiene B., Johansson A.K., Sergejeva S., Lundin S., Sjostrand M., and Lotvall J. Regulation of bone marrow and airway CD34+ eosinophils by interleukin-5. Am J Respir Cell Mol Biol 30 (2004) 367-378
3. Denburg J.A., Sehmi R., Saito H., Pil-Seob J., Inman M.D., and O'Byrne P.M. Systemic aspects of allergic disease: bone marrow responses. J Allergy Clin Immunol 106 (2000) S242-S246
4. Dorman S.C., Sehmi R., Gauvreau G.M., Watson R.M., Foley R., Jones G.L., et al. Kinetics of bone marrow eosinophilopoiesis and associated cytokines after allergen inhalation. Am J Respir Crit Care Med 169 (2004) 565-572
5. Wood L.J., Sehmi R., Gauvreau G.M., Watson R.M., Foley R., Denburg J.A., et al. An inhaled corticosteroid, budesonide, reduces baseline but not allergen-induced increases in bone marrow inflammatory cell progenitors in asthmatic subjects. Am J Respir Crit Care Med 159 (1999) 1457-1463
6. Wang C.H., Lin H.C., Lin C.H., Yu C.T., Liu S.L., Huang K.H., et al. Effect of theophylline and specific phosphodiesterase IV inhibition on proliferation and apoptosis of progenitor cells in bronchial asthma. Br J Pharmacol 138 (2003) 1147-1155
7. Niven A.S., and Argyros G. Alternate treatments in asthma. Chest 123 (2003) 1254-1265
8. Rohatagi S., Calic F., Harding N., Ozoux M.L., Bouriot J.P., Kirkesseli S., et al. Pharmacokinetics, pharmacodynamics, and safety of inhaled cyclosporin A (ADI628) after single and repeated administration in healthy male and female subjects and asthmatic patients. J Clin Pharmacol 40 (2000) 1211-1226
9. Underwood S.L., McMillan S., Reeves R., Hunt J., Brealey C.J., Webber S., et al. Effects of cyclosporin A administered into the airways against antigen-induced airway inflammation and hyperreactivity in the rat. Eur J Pharmacol 420 (2001) 165-173
10. Pareja-Ciuro F., Diez-Canedo J.S., Gomez-Bravo M.A., Garcia-Gonzalez I., Tamayo-Lopez M.J., Sousa-Martin J.M., et al. Efficacy and safety of mycophenolate mofetil as part of induction therapy in liver transplantation. Transplant Proc 37 (2005) 3926-3929
11. Gonzalez-Roncero F.M., Gentil M.A., Brunet M., Algarra G., Pereira P., Cabello V., et al. Pharmacokinetics of mycophenolate mofetil in kidney transplant patients with renal insufficiency. Transplant Proc 37 (2005) 3749-3751
12. Swigris J.J., Olson A.L., Fischer A., Lynch D.A., Cosgrove G.P., Frankel S.K., et al. Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease. Chest 130 (2006) 30-36
13. Tse K.C., Tang C.S., Lio W.I., Lam M.F., and Chan T.M. Quality of life comparison between corticosteroid-and-mycofenolate mofetil and corticosteroid-and-oral cyclophosphamide in the treatment of severe lupus nephritis. Lupus 15 (2006) 371-379
14. Wu Y.G., Lin H., Qian H., Zhao M., Qi X.M., Wu G.Z., et al. Renoprotective effects of combination of angiotensin converting enzyme inhibitor with mycophenolate mofetil in diabetic rats. Inflamm Res 55 (2006) 192-199
15. Mele T.S., and Halloran P.F. The use of mycophenolate mofetil in transplant recipients. Immunopharmacology 47 (2000) 215-245
16. Raab M., Daxecker H., Karimi A., Markovic S., Cichna M., Markl P., et al. In vitro effects of mycophenolic acid on the nucleotide pool and on the expression of adhesion molecules of human umbilical vein endothelial cells. Clin Chim Acta 310 (2001) 89-98
17. Colic M., Stojic-Vukanic Z., Pavlovic B., Jandric D., and Stefanoska I. Mycophenolate mofetil inhibits differentiation, maturation and allostimulatory function of human monocyte-derived dendritic cells. Clin Exp Immunol 134 (2003) 63-69
18. Yao H., Zhou J., Li D., Wu N., Bader A., Hoxtermann S., et al. FK506 enhances triptolide-induced down-regulation of cyclooxygenase-2, inducible nitric oxide synthase as well as their products PGE2 and NO in TNF-alpha-stimulated synovial fibroblasts from rheumatoid arthritic patients. Eur J Med Res 10 (2005) 110-116
19. Qiu D., and Kao P.N. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook F. Drugs R D 4 (2003) 1-18
20. Zhang N., Xu Y.J., and Zhang Z.X. Regulatory function of nuclear factor kappa B on lymphocyte proliferation and apoptosis in bronchial asthmatic rats and effect of triptolide on the regulation. Chin J Integr Tradit Chin West Med 24 (2004) 435-438
21. Lin K.X., Wang C.Z., and Qian G.S. Effect of Tripterygium wilfordii on Th1, Th2 cytokines production in asthma patients. Chin J Integr Tradit Chin West Med 21 (2001) 22-24
22. Fulkerson P.C., Zimmermann N., Hassman L.M., Finkelman F.D., and Rothenberg M.E. Pulmonary chemokine expression is coordinately regulated by STAT1, STAT6, and IFN-gamma. J Immunol 173 (2004) 7565-7574
23. Tomaki M., Zhao L.L., Lundahl J., Sjostrand M., Jordana M., Linden A., et al. Eosinophilopoiesis in a murine model of allergic airway eosinophilia: involvement of bone marrow IL-5 and IL-5 receptor alpha. J Immunol 165 (2000) 4040-4050
24. Hamid Q., Barkans J., Meng Q., Ying S., Abrams J.S., Kay A.B., et al. Human eosinophils synthesize and secrete interleukin-6 in vitro. Blood 80 (1992) 1496-1501
25. Mao H., Wang Z.L., Li F.Y., Liu C.T., and Lei S. Relationship between bone marrow-derived CD34 + cells expressing interleukin-5 receptor messenger RNA and asthmatic airway inflammation. Chin Med J 117 (2004) 24-29
26. Powell N., Till S., Bungre J., and Corrigan C. The immunomodulatory drugs cyclosporin A, mycophenolate mofetil, and sirolimus (rapamycin) inhibit allergen-induced proliferation and IL-5 production by PBMCs from atopic asthmatic patients. J Allergy Clin Immunol 108 (2001) 915-917
27. Wang X.H., and Zhang Z.Y. Effect of tripterygium polyglucoside on T-lymphocyte subsets and serum interleukin-5 level in asthma patients. Chin J Integr Tradit Chin West Med 21 (2001) 25-27
28. Lu Y., Liu Y., Fukuda K., Nakamura Y., Kumagai N., and Nishida T. Inhibition by triptolide of chemokine, proinflammatory cytokine, and adhesion molecule expression induced by lipopolysaccharide in corneal fibroblasts. Invest Ophthalmol Vis Sci 47 (2006) 3796-3800
29. Yang Y., Liu Z., Tolosa E., Yang J., and Li L. Triptolide induces apoptotic death of T lymphocyte. Immunopharmacology 40 (1998) 139-149
30. Menzies-Gow A., Flood-Page P., Sehmi R., Burman J., Hamid Q., Robinson D.S., et al. Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics. J Allergy Clin Immunol 111 (2003) 714-719
31. Greenfeder S., Umland S.P., Cuss F.M., Chapman R.W., and Egan R.W. Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease. Respir Res 2 (2001) 71-79
32. Sehmi R., Baatjes A.J., and Denburg J.A. Hemopoietic progenitor cells and hemopoietic factors: potential targets for treatment of allergic inflammatory diseases. Curr Drug Targets Inflamm Allergy 2 (2003) 271-278
33. Shen H., O'Byrne P.M., Ellis R., Wattie J., Tang C., and Inman M.D. The effects of intranasal budesonide on allergen-induced production of interleukin-5 and eotaxin, airways, blood, and bone marrow eosinophilia, and eosinophil progenitor expansion in sensitized mice. Am J Respir Crit Care Med 166 (2002) 146-153
34. Denburg J.A., Sehmi R., and Upham J. Regulation of IL-5 receptor on eosinophil progenitors in allergic inflammation: role of retinoic acid. Int Arch Allergy Immunol 124 (2001) 246-248
35. Sehmi R., Dorman S., Baatjes A., Watson R., Foley R., Ying S., et al. Allergen-induced fluctuation in CC chemokine receptor 3 expression on bone marrow CD34+ cells from asthmatic subjects: significance for mobilization of haemopoietic progenitor cells in allergic inflammation. Immunology 109 (2003) 536-546
36. Dorman S.C., Babirad I., Post J., Watson R.M., Foley R., Jones G.L., et al. Progenitor egress from the bone marrow after allergen challenge: role of stromal cell-derived factor 1alpha and eotaxin. J Allergy Clin Immunol 115 (2005) 501-507
37. Southam D.S., Widmer N., Ellis R., Hirota J.A., Inman M.D., and Sehmi R. Increased eosinophil-lineage committed progenitors in the lung of allergen-challenged mice. J Allergy Clin Immunol 115 (2005) 95-102